IP Library Granted Patent US 8,323,659
Granted Patent B2
US 8,323,659 · App. 13/119,645 · Granted Dec 4, 2012

Method for diagnosing and/or treating tumor

Assignee: Keio University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,323,659
App. No.
13/119,645
Granted
Dec 4, 2012
Kind
B2
Abstract

An object of the present invention is to provide methods for diagnosing and/or treating tumors using HERV-H env gene or HERV-H env Env protein. Specifically, tumors are diagnosed by detecting expression of HERV-H env gene; and agents for detecting the expression are used as diagnosing agents. Further, tumors are treated by inhibiting function of HERV-H env gene; and agents for inhibiting the function are used as antitumor agents. Furthermore, tumors are treated by administering a peptide having a certain sequence of HERV-H Env protein and the like; and the peptide is used as a cancer vaccine.

Claims (5)

1. An isolated peptide consisting of any one of SEQ ID NOs: 3 to 5.

2. An isolated antigen-presenting cell presenting a peptide according to claim 1 on the cell surface.

3. A composition comprising a peptide according to claim 1 , or an expression vector expressing a peptide according to claim 1 .

4. A composition comprising a peptide of claim 1 and a tumor antigen peptide other than the peptide.

5. A composition comprising the isolated antigen-presenting cell according to claim 2 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2011
From: KUDO, CHIE; KAWAKAMI, YUTAKA
To: KEIO UNIVERSITY
Reel/Frame 026181/0277 →
Priority Claims (1)
JP 2008-239943 · Sep 18, 2008 · national
Continuity (1)
Related Publication 20110217326A1 · Sep 8, 2011